Longitudinal changes of insulin sensitivity in essential hypertension: Influence of blood pressure control and familial predisposition to hypertension

Journal of Clinical Endocrinology and Metabolism

Volumn 86, Issue 7, 2001, Pages 3027-3031

  Grandi, Anna M ^a,c   Zanzi, Paolo ^a   Broggi, Roberta ^a   Fachinetti, Anna ^b   Guasti, Luigina ^a   Ceriani, Luca ^b   Venco, Achille ^a  

^a UNIVERSITY OF INSUBRIA   (Italy)

^b OSPEDALE DI CIRCOLO   (Italy)

^c NONE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; C PEPTIDE; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; FELODIPINE; FOSINOPRIL; GLUCOSE; INSULIN; ISRADIPINE; PERINDOPRIL;

ARTICLE; BLOOD PRESSURE REGULATION; DISEASE PREDISPOSITION; ESSENTIAL HYPERTENSION; FAMILY HISTORY; FEMALE; HUMAN; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; METABOLIC CLEARANCE RATE; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL;

EID: 0034920603     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.86.7.7619     Document Type: Article

References (36)

1. Cardiovascular risk factors and their interactions in hypertensives
2. Metabolic predictors of hypertension
3. Hypertension and associated metabolic abnormalities: The role of insulin resistance and the sympathoadrenal system
4. Hypertriglyceridemia, insulin resistance and the metabolic syndrome
5. Insulin resistance in essential hypertension
6. Insulin resistance is a characteristic feature of primary, hypertension independent of obesity
7. The hemodynamic link between insulin resistance and hypertension
8. Insulin resistance: The shape of things to come
9. Insulin resistance, hyperinsulinemia and hypertension: Causes, consequences or merely correlations?
10. Clonidine prevents insulin resistance and hypertension in obese dogs
11. Insulin resistance in systemic hypertension: Pharmacotherapeutic implications
12. Hyperinsulinemia, insulin resistance and the treatment of hypertension
13. Effects of calcium antagonists on insulin sensitivity and other metabolic parameters
14. Hyperinsulinemia and insulin resistance in hypertension: Differential effects of antihypertensive agents
15. A double blind comparison of the effects of amlodipine and enalapril on insulin sensitivity in hypertensive patients
16. Altered insulin sensitivity, hyperinsulinemia and dyslipidemia in individuals with a hypertensive parent
17. Insulin resistance in offspring of hypertensive parents
18. Insulin resistance is coupled to low physical fitness in normotensive men with a family history of hypertension
19. Hyperinsulinemia, family history of hypertension and essential hypertension
20. Differences in insulin and sympathetic responses to glucose ingestion due to family history of hypertension
21. Influence of family history of hypertension on insulin sensitivity in lean and obese hypertensive subjects
22. Insulin sensitivity in obese normotensive adults: Influence of family history of hypertension
23. Hyperinsulinemia increases blood pressure in genetically predisposed spontaneously hypertensive rats but not in normotensive Wistar-Kyoto rats
24. Genetic factors determine blood pressure response to insulin resistance and hyperinsulinemia: A call to refocus the insulin hypothesis of hypertension
25. Insulin and diastolic dysfunction in lean and obese hypertensives: Genetic influence
26. Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity
27. The ACE-inhibitor lisinopril affects plasma insulin levels but not fibrinolytic parameters
28. Lisinopril versus hydrochlorothiazide in obese hypertensive patients: A multicenter placebo-controlled trial
29. Metabolic neutrality of perindopril: Focus on insulin sensitivity in overweight patients with essential hypertension
30. Controlled study of the effect of angiotensin converting enzyme inhibition versus calcium-entry blockade on insulin sensitivity in overweight hypertensive patients: Trandolapril Italian Study (TRIS)
31. Antihypertensive therapy and insulin sensitivity: Do we have to redefine the role of β-blocking agents?
32. A comparison of the effects of hydrochlorothiazide and captopril on glucose and lipid metabolism in patients with hypertension
33. Effects of antihypertensives on insulin sensitivity with special reference to ACE inhibitors
34. Insulin and blood pressure during weight loss in obese adolescents
35. Insulin resistance: A multifaced syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia and atherosclerotic cardiovascular disease
36. Effect of weight loss on blood pressure and insulin resistance in normotensives and hypertensive obese individuals